I am planning to buy a new eBike, most likely with an Avinox M2S with a fixed battery. I store my current bike in a ventilated garden shed. In summer the outside temperate is 20C (70F) but with recent heat weaves we get to 33C (90F). This should be fine - it may just accelerate the aging of battery.

What I worry more is storage (not charging!) in the winter where temperatures can go below -10C (15F), and few days it can go to -15C (5F) or lower. Li-ion chemistry should be totally fine with those temperatures in storage and actually it will significantly slow down the aging process of the battery. But Avinox lists the storage temperature range above freezing point (0C) - up to 40C (105F). Would freezing temps damage something in the electronic part or is Avinox just being cautious and it will be completely fine?

I am aware that charging a battery below freezing temps will damage it - in that case I would use a heating pad or bring the bike in. And yes a removable battery would be the best solution but the trend is now integrated batteries and the removable batteries weight considerably more / and have other downsides.

I don't really want to take up space at my home with a bike during winter.

Claude AI summary:

TL;DR: Headline was ugly (-$0.13 EPS vs -$0.05 est, $25.1M revenue vs ~$30M est). Strip out $10.7M of one-time VAC/ASM transaction costs and a $2.1M write-off of a non-core investment and the core loss is roughly in line. Meanwhile the filing shows a 57% gross margin (vs ~0% a year ago), a deliberate inventory build instead of dumping pounds at $85 spot, ~$961M of liquidity, and cash burn cut nearly in half. One yellow flag: ASM close slipped from early July to end of August.

The "miss" decomposed

Net loss was $33.6M. But Q2 absorbed:

• $10.7M in transaction & integration costs (VAC + ASM advisory, legal, financing fees) — that's ~$0.04/share of the miss right there, and it's one-time deal spend, not operations
• ~$2.1M Tate write-off — they walked away from a small non-core stake instead of throwing more money at it. That's discipline showing up as a loss.

Underlying operating loss lands around -$0.08/sh — for a company mid-buildout, unremarkable.

Revenue "missed" for the most bullish possible reason (see next section).

Gross margin: the number nobody is talking about

Q2 2026: $25.1M revenue vs $10.7M costs applicable to revenue = ~57% gross margin. Q2 2025: $4.2M revenue vs $3.7M costs = ~12%.

This is the low-cost Pinyon Plain ore ($23–30/lb mining + $9–12/lb processing, per the June update) finally flowing through GAAP financials. The uranium business is now structurally profitable at the gross line.

Warehousing confirmed — low revenue is a choice

Concentrate + WIP inventory grew from $44.2M to $61.4M while ore stockpiles were drawn down and processed. Translation: they produced ~1.6Mlb in H1 (full-year guidance hit by June 30) and are deliberately sitting on finished pounds instead of selling into an $85 spot market, waiting for contract deliveries and better prices. Revenue is low because management wants it low. If you're valuing this company on current revenue, you're measuring the wrong thing.

Balance sheet

• ~$58M cash + ~$903M marketable securities ≈ $961M liquid
• $700M convertible at 0.75% coupon (1.38% effective), $20.34 conversion price, with capped calls on top
• Working capital ~$996M
• H1 operating cash flow: -$17.8M vs -$44.8M a year ago — burn nearly halved

The $718M cash portion of the VAC deal is fully funded from the balance sheet with room to spare, before the $250M Goldman term loan and the conditional $725M OSC government loan even enter the picture.

New information in the filing

The yellow flag: ASM close moved from "early July" to end of August 2026. Australian FIRB approval is done, it's court/shareholder mechanics now — reads like process, not trouble — but it's the first date in the sequence to slip, so worth watching.

The green flags:

• VAC close now stated "as early as Q1 2027" — marginally earlier than prior "early 2027" language
• Donald Project: no FID yet (that's the big Q3 catalyst), but they advanced another ~AUD$21M during the half for land and mineral separation equipment, lifted their JV stake to 12.7%, and are targeting AUD$220M in project debt. You don't buy the separation equipment for a project you expect to cancel.
• ATM usage: they sold 5.3M shares in Q2 at an average of ~$19.40. Yes it's dilution — but note the sequencing: the company sold stock near $19, and the CEO personally bought ~$1M at $13.08 in July. Management is telling you where they think both edges of the range are.

What I'm watching next

1. Donald FID — due this quarter, the single biggest near-term catalyst
2. VAC regulatory progress (German approval)
3. ASM actually closing end of August
4. Whether the utility contracting cycle accelerates into year-end (the thing that actually moves this stock)